[Diabetic Neuropathy and Diabetic Foot Syndrome (Update 2019)]

Overview

Journal Wien Klin Wochenschr

Publisher Springer

Specialty General Medicine

Date 2019 Apr 14

PMID 30980143

Citations 11

Authors

Monika Lechleitner

Heidemarie Abrahamian

Claudia Francesconi

Markus Kofler

Wolfgang Sturm

Gerd Kohler

Affiliations

Soon will be listed here.

Abstract

These are the guidelines for diagnosis and treatment of diabetic neuropathy and diabetic foot. Diabetic neuropathy comprises a number of mono- and polyneuropathies, plexopathies, radiculopathies and autonomic neuropathy.The position statement summarizes characteristic clinical symptoms and techniques for diagnostic assessment of diabetic neuropathy, including the complex situation of the diabetic foot syndrome. Recommendations for the therapeutic management of diabetic neuropathy, especially for the control of pain in sensorimotor neuropathy, are provided. The needs to prevent and treat diabetic foot syndrome are summarized.

Citing Articles

Can Spinal Cord Stimulation be Considered as a Frontier for Chronic Pain in Diabetic Foot?.

Zhang Y, Zhang H, Wang K, Liu X, Li Z Pain Ther. 2025; .

PMID: 39910016 DOI: 10.1007/s40122-025-00710-0.

Predictive power of isolated high home systolic blood pressure for cardiovascular outcomes in individuals with type 2 diabetes mellitus: KAMOGAWA-HBP study.

Hosomi Y, Ushigome E, Kitagawa N, Kitagawa N, Tanaka T, Hasegawa G Diab Vasc Dis Res. 2023; 20(6):14791641231221264.

PMID: 38063417 PMC: 10710111. DOI: 10.1177/14791641231221264.

The Metabolic Characteristics of Patients at the Risk for Diabetic Foot Ulcer: A Comparative Study of Diabetic Patients with and without Diabetic Foot.

Li X, Wen S, Dong M, Yuan Y, Gong M, Wang C Diabetes Metab Syndr Obes. 2023; 16:3197-3211.

PMID: 37867628 PMC: 10590077. DOI: 10.2147/DMSO.S430426.

The Use of Medical Grade Honey on Infected Chronic Diabetic Foot Ulcers-A Prospective Case-Control Study.

Holubova A, Chlupacova L, Krocova J, Cetlova L, Peters L, Cremers N Antibiotics (Basel). 2023; 12(9).

PMID: 37760661 PMC: 10525154. DOI: 10.3390/antibiotics12091364.

Advances and perspective on animal models and hydrogel biomaterials for diabetic wound healing.

Hu Y, Xiong Y, Tao R, Xue H, Chen L, Lin Z Biomater Transl. 2023; 3(3):188-200.

PMID: 36654776 PMC: 9840091. DOI: 10.12336/biomatertransl.2022.03.003.

References

Ramsey S, Newton K, Blough D, McCulloch D, Sandhu N, Reiber G . Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999; 22(3):382-7. DOI: 10.2337/diacare.22.3.382. View

Sima A, Sugimoto K . Experimental diabetic neuropathy: an update. Diabetologia. 1999; 42(7):773-88. DOI: 10.1007/s001250051227. View

Jude E, Oyibo S, Chalmers N, Boulton A . Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001; 24(8):1433-7. DOI: 10.2337/diacare.24.8.1433. View

Yagihashi S, Yamagishi S, Wada Ri R, Baba M, Hohman T, Yabe-Nishimura C . Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain. 2001; 124(Pt 12):2448-58. DOI: 10.1093/brain/124.12.2448. View

van de Poll-Franse L, Valk G, Renders C, Heine R, van Eijk J . Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factors. Diabet Med. 2002; 19(9):771-6. DOI: 10.1046/j.1464-5491.2002.00778.x. View

Meijer J, Bosma E, Lefrandt J, Links T, Smit A, Stewart R . Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores. Diabetes Care. 2003; 26(3):697-701. DOI: 10.2337/diacare.26.3.697. View

Ziegler D . Diagnosis and treatment of diabetic autonomic neuropathy. Curr Diab Rep. 2003; 1(3):216-27. DOI: 10.1007/s11892-001-0037-3. View

Vinik A, Maser R, Mitchell B, Freeman R . Diabetic autonomic neuropathy. Diabetes Care. 2003; 26(5):1553-79. DOI: 10.2337/diacare.26.5.1553. View

Malik R, Kallinikos P, Abbott C, van Schie C, Morgan P, Efron N . Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia. 2003; 46(5):683-8. DOI: 10.1007/s00125-003-1086-8. View

10.

Rahman M, Griffin S, Rathmann W, Wareham N . How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures. Diabet Med. 2003; 20(5):368-74. DOI: 10.1046/j.1464-5491.2003.00931.x. View

11.

Singh N, Armstrong D, Lipsky B . Preventing foot ulcers in patients with diabetes. JAMA. 2005; 293(2):217-28. DOI: 10.1001/jama.293.2.217. View

12.

Dyck P, Karnes J, OBrien P, Litchy W, Low P, Melton 3rd L . The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology. 1992; 42(6):1164-70. DOI: 10.1212/wnl.42.6.1164. View

13.

Martin C, Albers J, Herman W, Cleary P, Waberski B, Greene D . Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care. 2006; 29(2):340-4. PMC: 2622720. DOI: 10.2337/diacare.29.02.06.dc05-1549. View

14.

Davies M, Brophy S, Williams R, Taylor A . The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006; 29(7):1518-22. DOI: 10.2337/dc05-2228. View

15.

Zochodne D . Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms. Muscle Nerve. 2007; 36(2):144-66. DOI: 10.1002/mus.20785. View

16.

Ziegler D . Treatment of diabetic neuropathy and neuropathic pain: how far have we come?. Diabetes Care. 2008; 31 Suppl 2:S255-61. DOI: 10.2337/dc08-s263. View

17.

Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M . Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358(24):2560-72. DOI: 10.1056/NEJMoa0802987. View

18.

Boulton A, Armstrong D, Albert S, Frykberg R, Hellman R, Kirkman M . Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008; 31(8):1679-85. PMC: 2494620. DOI: 10.2337/dc08-9021. View

19.

Holman R, Paul S, Bethel M, Matthews D, Neil H . 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359(15):1577-89. DOI: 10.1056/NEJMoa0806470. View

20.

Guastella V, Mick G . Strategies for the diagnosis and treatment of neuropathic pain secondary to diabetic peripheral sensory polyneuropathy. Diabetes Metab. 2008; 35(1):12-9. DOI: 10.1016/j.diabet.2008.09.003. View